George Farmer
Stock Analyst at Scotiabank
(1.65)
# 3,138
Out of 4,840 analysts
74
Total ratings
26.83%
Success rate
-9.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACLX Arcellx | Maintains: Sector Outperform | $133 → $93 | $61.95 | +50.12% | 2 | May 9, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $9.93 | +71.20% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $3.16 | +279.75% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $6.18 | +45.63% | 4 | Apr 10, 2025 | |
| ADAP Adaptimmune Therapeutics | Maintains: Sector Outperform | $3.15 → $1.4 | $0.28 | +399.46% | 2 | Mar 21, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $24.24 | +69.14% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $17.01 | +205.70% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $58.11 | +37.67% | 8 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Sector Outperform | $244 → $224 | $128.39 | +74.47% | 3 | Feb 13, 2025 | |
| VKTX Viking Therapeutics | Initiates: Sector Outperform | $102 | $27.18 | +275.28% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $14 → $12 | $6.52 | +84.05% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $22 → $23 | $7.65 | +200.65% | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $5.61 | +78.25% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $579.77 | +23.32% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $5.99 | +283.97% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $2.20 | +809.09% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $21 → $41 | $1.42 | +2,787.32% | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $28.76 | +164.26% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $2.72 | +377.94% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $26.76 | +307.32% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $65.33 | +33.17% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $1.30 | +2,438.46% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.89 | +4,394.38% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $43.09 | -37.34% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $100.06 | -25.04% | 3 | Apr 29, 2020 |
Arcellx
May 9, 2025
Maintains: Sector Outperform
Price Target: $133 → $93
Current: $61.95
Upside: +50.12%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $9.93
Upside: +71.20%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $3.16
Upside: +279.75%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $6.18
Upside: +45.63%
Adaptimmune Therapeutics
Mar 21, 2025
Maintains: Sector Outperform
Price Target: $3.15 → $1.4
Current: $0.28
Upside: +399.46%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $24.24
Upside: +69.14%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $17.01
Upside: +205.70%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $58.11
Upside: +37.67%
Biogen
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $128.39
Upside: +74.47%
Viking Therapeutics
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $27.18
Upside: +275.28%
Feb 12, 2025
Maintains: Sector Outperform
Price Target: $14 → $12
Current: $6.52
Upside: +84.05%
Feb 11, 2025
Maintains: Sector Outperform
Price Target: $22 → $23
Current: $7.65
Upside: +200.65%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $5.61
Upside: +78.25%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $579.77
Upside: +23.32%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $5.99
Upside: +283.97%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $2.20
Upside: +809.09%
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $1.42
Upside: +2,787.32%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $28.76
Upside: +164.26%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $2.72
Upside: +377.94%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $26.76
Upside: +307.32%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $65.33
Upside: +33.17%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $1.30
Upside: +2,438.46%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.89
Upside: +4,394.38%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $43.09
Upside: -37.34%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $100.06
Upside: -25.04%